Genetics and visceral leishmaniasis: of mice and man
- PMID: 19388946
- PMCID: PMC3160815
- DOI: 10.1111/j.1365-3024.2009.01102.x
Genetics and visceral leishmaniasis: of mice and man
Abstract
Ninety per cent of the 500,000 annual new cases of visceral leishmaniasis (VL) occur in India/Bangladesh/Nepal, Sudan and Brazil. Importantly, 80-90% of human infections are sub-clinical or asymptomatic, usually associated with strong cell-mediated immunity. Understanding the environmental and genetic risk factors that determine why two people with the same exposure to infection differ in susceptibility could provide important leads for improved therapies. Recent research using candidate gene association analysis and genome-wide linkage studies (GWLS) in collections of families from Sudan, Brazil and India have identified a number of genes/regions related both to environmental risk factors (e.g. iron), as well as genes that determine type 1 vs. type 2 cellular immune responses. However, until now all of the allelic association studies carried out have been underpowered to find genes of small effect sizes (odds ratios or OR < 2), and GWLS using multicase pedigrees have only been powered to find single major genes, or at best oligogenic control. The accumulation of large DNA banks from India and Brazil now makes it possible to undertake genome-wide association studies (GWAS), which are ongoing as part of phase 2 of the Wellcome Trust Case Control Consortium. Data from this analysis should seed research into novel genes and mechanisms that influence susceptibility to VL.
Conflict of interest statement
Disclosures The authors declare no conflicts of interest
Figures


Similar articles
-
A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis-an experimental study.Parasitol Int. 2014 Aug;63(4):612-20. doi: 10.1016/j.parint.2014.04.002. Epub 2014 Apr 18. Parasitol Int. 2014. PMID: 24747611
-
Genome-wide scan for visceral leishmaniasis susceptibility genes in Brazil.Genes Immun. 2007 Jan;8(1):84-90. doi: 10.1038/sj.gene.6364357. Epub 2006 Nov 23. Genes Immun. 2007. PMID: 17122780 Free PMC article.
-
Classification and regression tree and spatial analyses reveal geographic heterogeneity in genome wide linkage study of Indian visceral leishmaniasis.PLoS One. 2010 Dec 31;5(12):e15807. doi: 10.1371/journal.pone.0015807. PLoS One. 2010. PMID: 21209823 Free PMC article.
-
Genetics and visceral leishmaniasis in the Sudan: seeking a link.Trends Parasitol. 2004 Jun;20(6):268-74. doi: 10.1016/j.pt.2004.04.003. Trends Parasitol. 2004. PMID: 15147677 Review. No abstract available.
-
Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study.Philos Trans R Soc Lond B Biol Sci. 1997 Sep 29;352(1359):1331-45. doi: 10.1098/rstb.1997.0118. Philos Trans R Soc Lond B Biol Sci. 1997. PMID: 9355125 Free PMC article. Review.
Cited by
-
Determinants for the development of visceral leishmaniasis disease.PLoS Pathog. 2013 Jan;9(1):e1003053. doi: 10.1371/journal.ppat.1003053. Epub 2013 Jan 3. PLoS Pathog. 2013. PMID: 23300451 Free PMC article. Review.
-
Lipoprotein lipase and PPAR alpha gene polymorphisms, increased very-low-density lipoprotein levels, and decreased high-density lipoprotein levels as risk markers for the development of visceral leishmaniasis by Leishmania infantum.Mediators Inflamm. 2014;2014:230129. doi: 10.1155/2014/230129. Epub 2014 Aug 27. Mediators Inflamm. 2014. PMID: 25242866 Free PMC article.
-
Comprehensive candidate gene analysis for symptomatic or asymptomatic outcomes of Leishmania infantum infection in Brazil.Ann Hum Genet. 2017 Jan;81(1):41-48. doi: 10.1111/ahg.12180. Epub 2017 Jan 4. Ann Hum Genet. 2017. PMID: 28054334 Free PMC article.
-
Validity of the polymerase chain reaction in the diagnosis of clinically suspected cases of American visceral leishmaniasis.Braz J Infect Dis. 2013 May-Jun;17(3):319-23. doi: 10.1016/j.bjid.2012.10.021. Epub 2013 May 15. Braz J Infect Dis. 2013. PMID: 23683573 Free PMC article.
-
Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani.Front Immunol. 2018 Oct 17;9:2420. doi: 10.3389/fimmu.2018.02420. eCollection 2018. Front Immunol. 2018. PMID: 30386348 Free PMC article.
References
-
- Badaro R, Jones TC, Lorenco R, et al. A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis. 1986;154:639–49. - PubMed
-
- Badaro R, Jones TC, Carvalho EM, et al. New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis. 1986;154:1003–9. - PubMed
-
- Ho M, Siongok TK, Lyerly WH, et al. Prevalence and disease spectrum in a new focus of visceral leishmaniasis in Kenya. Trans R Soc Trop Med Hyg. 1982;76:741–6. - PubMed
-
- Sacks DL, Lal SL, Shrivastava SN, et al. An analysis of T cell responsiveness in Indian Kala-azar. J Immunol. 1987;138:908–13. - PubMed
-
- Vallance P, Levick M. Drug discovery and development in the age of molecular medicine. Clin Pharmacol Ther. 2007;82(4):363–6. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources